Finally, several genes in the [NASH]vs[NAFLD + HC] signature (e.g. CHST9, DPYSL2) have not been previously implicated in liver disease and could potentially provide novel biological insights into NASH etiology. This evidence concerns the gene CHST9 and liver disorder.